MDRM Company Profile and Key Details

Average 10-day trading volume of 279.43 thousand shares is slightly above the 3-month average of 192.55 thousand, indicating heightened recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

The stock is currently mid-range between its 52-week high and low $0.00 and $0.01. With a market capitalization of about $1.28 million, Modern Mobility Aids, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.25). Key stats such as the average daily volume over the past year has been around 77.35 thousand shares, trading with heavier-than-usual volume. Headquartered in Brampton, ON, Modern Mobility Aids, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Tito Di Marco, the company employs approximately 8 people and listed since July 01, 2014. Modern Mobility Aids, Inc. operates in the telehealth and telemedicine industry.

Our AI price prediction model suggests that Galileo Life Sciences, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Galileo Life Sciences, Inc. trading at a premium to the broader market with a P/E of -127.85.

Galileo Life Sciences, Inc. trades at a P/E ratio of -127.85, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -3.16 indicating negative book value, which may reflect financial stress. The P/FCF stands at 689.45, also above market averages.